Interim results from a multicentre clinical trial of T-3761 in Japan.
Kobayashi
H
H
Department of Internal Medicine, Kyorin University, Tokyo, Japan.
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D004305:Dose-Response Relationship, Drug; D024841:Fluoroquinolones; D006801:Humans; D007564:Japan; D010078:Oxazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D010078:Oxazines; C078052:pazufloxacin